Indefinite Delivery Contract SPE2DX18D9157

This Indefinite Delivery Contract (IDC) award with a ceiling value of $4,999,999 was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The IDC encompasses various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain. The contract provides direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites, covering an extensive portfolio of pharmaceutical products across multiple medical domains, including oncology treatments, contraceptives, and specialized pharmaceutical products.